FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894877589> ?p ?o ?g. }

• W2894877589 endingPage "217" @default.
• W2894877589 startingPage "209" @default.
• W2894877589 abstract "There is an unmet need to better understand the effectiveness of different biologics in inflammatory bowel diseases. We aimed at performing a multicentre, real-life comparison of the effectiveness of infliximab [IFX] and adalimumab [ADA] in Crohn's disease [CD].Data of consecutive patients with CD treated with IFX and ADA from January 2013 to May 2017 were extracted from the cohort of the Sicilian Network for Inflammatory Bowel Disease. We used propensity score-matching accounting for the main baseline characteristics in TNF-α inhibitor-naïve and non-naïve patients.A total of 632 patients [735 total treatments] were included. Among naïve patients, a clinical benefit [the sum of steroid-free remission plus clinical response] was achieved in 81.8% patients treated with ADA and in 77.6% patients treated with IFX (adjusted odds ratio [OR]: 1.23, 95% CI 0.63-2-44, p = 0.547] at 12 weeks; after 1 year, a clinical benefit was achieved in 69.2% of patients treated with ADA and in 64.5% patients treated with IFX [adjusted OR: 1.10, 95% CI 0.61-1.96, p = 0.766]. Among non-naïve patients, a clinical benefit was achieved in 61.7% of patients treated with ADA and in 68.1% of patients treated with IFX [adjusted OR: 0.72, 95% CI 0.21-2.44, p = 0.600] at 12 weeks; after 1 year, a clinical benefit was achieved in 48.9% of patients treated with ADA and in 40.4% patients treated with IFX [adjusted OR: 1.23, 95% CI 0.54-2.86, p = 0.620].In this propensity score-matched comparison of ADA and IFX in CD, both drugs showed high rates of clinical benefit, without significant differences between them." @default.
• W2894877589 created "2018-10-12" @default.
• W2894877589 creator A5000268699 @default.
• W2894877589 creator A5003162215 @default.
• W2894877589 creator A5006273594 @default.
• W2894877589 creator A5007719681 @default.
• W2894877589 creator A5008838958 @default.
• W2894877589 creator A5010932748 @default.
• W2894877589 creator A5012145560 @default.
• W2894877589 creator A5016678827 @default.
• W2894877589 creator A5018231363 @default.
• W2894877589 creator A5029574178 @default.
• W2894877589 creator A5032301313 @default.
• W2894877589 creator A5032603713 @default.
• W2894877589 creator A5045386060 @default.
• W2894877589 creator A5052439420 @default.
• W2894877589 creator A5052922410 @default.
• W2894877589 creator A5059183871 @default.
• W2894877589 creator A5064008147 @default.
• W2894877589 creator A5066032102 @default.
• W2894877589 creator A5066459416 @default.
• W2894877589 creator A5067231655 @default.
• W2894877589 creator A5068693559 @default.
• W2894877589 creator A5070847739 @default.
• W2894877589 creator A5075167160 @default.
• W2894877589 creator A5079051504 @default.
• W2894877589 creator A5080410805 @default.
• W2894877589 creator A5081551616 @default.
• W2894877589 creator A5088248608 @default.
• W2894877589 creator A5088747314 @default.
• W2894877589 date "2018-10-06" @default.
• W2894877589 modified "2023-09-28" @default.
• W2894877589 title "A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn’s Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease" @default.
• W2894877589 cites W2013592287 @default.
• W2894877589 cites W2019062711 @default.
• W2894877589 cites W2034795132 @default.
• W2894877589 cites W2036193982 @default.
• W2894877589 cites W2056917411 @default.
• W2894877589 cites W2070315801 @default.
• W2894877589 cites W2096675088 @default.
• W2894877589 cites W2120539905 @default.
• W2894877589 cites W2143747121 @default.
• W2894877589 cites W2335895559 @default.
• W2894877589 cites W2404971681 @default.
• W2894877589 cites W2418156720 @default.
• W2894877589 cites W2523706394 @default.
• W2894877589 cites W2525802576 @default.
• W2894877589 cites W2554182402 @default.
• W2894877589 cites W2600357914 @default.
• W2894877589 cites W2771677620 @default.
• W2894877589 doi "https://doi.org/10.1093/ecco-jcc/jjy156" @default.
• W2894877589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30295785" @default.
• W2894877589 hasPublicationYear "2018" @default.
• W2894877589 type Work @default.
• W2894877589 sameAs 2894877589 @default.
• W2894877589 citedByCount "27" @default.
• W2894877589 countsByYear W28948775892019 @default.
• W2894877589 countsByYear W28948775892020 @default.
• W2894877589 countsByYear W28948775892021 @default.
• W2894877589 countsByYear W28948775892022 @default.
• W2894877589 countsByYear W28948775892023 @default.
• W2894877589 crossrefType "journal-article" @default.
• W2894877589 hasAuthorship W2894877589A5000268699 @default.
• W2894877589 hasAuthorship W2894877589A5003162215 @default.
• W2894877589 hasAuthorship W2894877589A5006273594 @default.
• W2894877589 hasAuthorship W2894877589A5007719681 @default.
• W2894877589 hasAuthorship W2894877589A5008838958 @default.
• W2894877589 hasAuthorship W2894877589A5010932748 @default.
• W2894877589 hasAuthorship W2894877589A5012145560 @default.
• W2894877589 hasAuthorship W2894877589A5016678827 @default.
• W2894877589 hasAuthorship W2894877589A5018231363 @default.
• W2894877589 hasAuthorship W2894877589A5029574178 @default.
• W2894877589 hasAuthorship W2894877589A5032301313 @default.
• W2894877589 hasAuthorship W2894877589A5032603713 @default.
• W2894877589 hasAuthorship W2894877589A5045386060 @default.
• W2894877589 hasAuthorship W2894877589A5052439420 @default.
• W2894877589 hasAuthorship W2894877589A5052922410 @default.
• W2894877589 hasAuthorship W2894877589A5059183871 @default.
• W2894877589 hasAuthorship W2894877589A5064008147 @default.
• W2894877589 hasAuthorship W2894877589A5066032102 @default.
• W2894877589 hasAuthorship W2894877589A5066459416 @default.
• W2894877589 hasAuthorship W2894877589A5067231655 @default.
• W2894877589 hasAuthorship W2894877589A5068693559 @default.
• W2894877589 hasAuthorship W2894877589A5070847739 @default.
• W2894877589 hasAuthorship W2894877589A5075167160 @default.
• W2894877589 hasAuthorship W2894877589A5079051504 @default.
• W2894877589 hasAuthorship W2894877589A5080410805 @default.
• W2894877589 hasAuthorship W2894877589A5081551616 @default.
• W2894877589 hasAuthorship W2894877589A5088248608 @default.
• W2894877589 hasAuthorship W2894877589A5088747314 @default.
• W2894877589 hasConcept C126322002 @default.
• W2894877589 hasConcept C141071460 @default.
• W2894877589 hasConcept C156957248 @default.
• W2894877589 hasConcept C17923572 @default.
• W2894877589 hasConcept C2777138892 @default.
• W2894877589 hasConcept C2778260677 @default.
• W2894877589 hasConcept C2779134260 @default.
• W2894877589 hasConcept C2779280984 @default.

• next